Paasa Logo

Hong Kong Stock Exchange · Healthcare

Invest in Medtide stock from India

Indian and foreign residents can buy Medtide (3880) shares directly through Paasa.

By Paasa · Updated

Medtide at a glance

Price
HK$20.72+HK$0.00 (0.00%)
Market cap
HK$2.94B
Day range
HK$19.65 – HK$21.18
P/E
—
Dividend yield
None
Volume
74.30K
1 month
-3.63%
6 months
-7.66%
YTD
-32.02%
1 year
-33.42%
5 years
-32.73%

Live chart and statistics

Peer comparison

CompanyTickerPriceMarket cap
Qyuns Therapeutics2509.HKHK$16.82HK$3.76B
China Resources Medical1515.HKHK$2.43HK$3.07B
Viva Biotech1873.HKHK$1.43HK$2.96B
Clover Biopharmaceuticals2197.HKHK$1.88HK$2.44B
Jiangsu Recbio Technology2179.HKHK$4.40HK$2.33B
Antengene6996.HKHK$3.40HK$2.30B
AIM Vaccine6660.HKHK$1.73HK$2.12B
VISEN Pharmaceuticals2561.HKHK$18.52HK$2.02B

Peers as grouped by the data provider. This is not an investment recommendation.

How to invest in Medtide from India

  1. Step 1

    Open your Paasa account

    KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Step 2

    Add funds from your Indian bank account

    Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to HKD when you buy.

  3. Step 3

    Search 3880 and buy

    Find Medtide by name or by its ticker, 3880, and place your order. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.

Why invest in Medtide from India

What Medtide does

Medtide Inc. operates as a contract research, development, and manufacturing organization (CRDMO), providing comprehensive services across the entire pharmaceutical lifecycle, from initial drug discovery and preclinical investigation through to clinical development and commercial-scale production. The company specializes in the synthesis of novel peptide chemical entities for discovery purposes, along with the development of peptide-based chemistry, manufacturing, and control (CMC) processes, and their subsequent commercial manufacturing. Medtide operates in the Biotechnology industry within the Healthcare sector.

Paasa handles the paperwork

Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.

Frequently asked questions

Can I buy Medtide stock from India?

Yes. Indian residents and NRIs can buy Medtide (3880) shares directly through Paasa. Medtide is listed on the Hong Kong Stock Exchange, in the Biotechnology industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.

Do I need to buy a full Medtide share?

Usually more than one, and not a fraction: many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. At HK$20.72 a share, size the order by the lot, not by the share.

How are Medtide dividends taxed for Indian investors?

Medtide trades on the Hong Kong Stock Exchange but is domiciled in China, so any withholding on its dividends follows that country's rules rather than those of Hong Kong. Dividends are taxed at your slab rate in India. Paasa's dividend report shows the gross amount and any tax withheld for each payment.

What tax do I pay in India when I sell Medtide shares?

Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks. In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the HKD/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.

Share this guide
Get started

Own global companies from India, safeguard against rupee depreciation

Book a short call with our team to understand how Paasa can work for you